News from Par Pharmaceutical, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

09 Jul, 2014, 08:00 ET Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...


21 Jan, 2014, 07:00 ET Par Pharmaceutical to Acquire JHP Pharmaceuticals

 Par Pharmaceutical Companies, Inc. ("Par") today announced  that it has entered into a definitive agreement to acquire JHP Group...


20 Nov, 2013, 09:00 ET Par Pharmaceutical Begins Shipment of Generic Focalin XR® Capsules

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg...


08 May, 2013, 12:09 ET Par Pharmaceutical Announces Quarterly Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review...


25 Oct, 2012, 10:01 ET Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules

 Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval...


28 Sep, 2012, 11:40 ET Par Announces Completion Of Acquisition By TPG

 Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This...


09 Apr, 2012, 09:00 ET Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012

 Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Tuesday, May 8, 2012 at...


06 Apr, 2012, 07:30 ET Par Pharmaceutical Begins Shipment of Generic Provigil®

Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it began shipping all strengths of modafinil tablets, a generic version of...


17 Nov, 2011, 12:45 ET Par Pharmaceutical Completes Acquisition of Anchen

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has completed its acquisition of Anchen Pharmaceuticals, a privately-held...


14 Oct, 2011, 16:15 ET Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES

Par Pharmaceutical, Inc., the wholly-owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it filed a declaratory...


24 Aug, 2011, 07:00 ET Par Pharmaceutical To Acquire Anchen Pharmaceuticals

Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a...


04 May, 2010, 07:30 ET Par Pharmaceutical Companies Reports Cash EPS and GAAP EPS of $0.75 for First Quarter 2010

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the first quarter ended March 31, 2010. For the first quarter ended...


05 Feb, 2010, 16:45 ET Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug...


01 Apr, 2009, 08:00 ET Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical

First and Only Once-weekly, Self-administered Alternative to Injections for Treatment of Vitamin B12 Deficiency Strativa Pharmaceuticals, the...


25 Feb, 2008, 00:00 ET Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine

WOODCLIFF LAKE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


15 Jan, 2008, 00:00 ET Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation

WOODCLIFF LAKE, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


04 May, 2004, 01:00 ET Par Pharmaceutical Begins Shipment of Generic Glucovance(R) Tablets

SPRING VALLEY, N.Y., May 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


12 Feb, 2004, 00:00 ET Par Pharmaceutical to Market Generic Purinethol(R) Tablets

SPRING VALLEY, N.Y., Feb. 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


28 Nov, 2003, 00:00 ET Par Pharmaceutical to Begin Shipment of Metformin Hydrochloride Extended-Release Tablets

SPRING VALLEY, N.Y., Nov. 28 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


06 Nov, 2003, 00:00 ET Par Pharmaceutical Announces Joint Development Agreement With Glatt

SPRING VALLEY, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


16 Sep, 2003, 01:00 ET Par Pharmaceutical Begins Shipment of Nefazodone Hydrochloride Tablets

SPRING VALLEY, N.Y., Sept. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


02 Sep, 2003, 01:00 ET Par Pharmaceutical Announces Agreement With Bristol-Myers Squibb for Megace(R)

SPRING VALLEY, N.Y., Sept. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


07 Jul, 2003, 01:00 ET Par Pharmaceutical Announces Licensing Agreement With Paddock Laboratories

SPRING VALLEY, N.Y., July 7 /PRNewswire-FirstCall/ - Pharmaceutical Resources, Inc. (NYSE: PRX) announced today that through its subsidiary, Par...


21 Oct, 2002, 01:00 ET Par Pharmaceutical Announces Filing Of Tramadol Hydrochloride Tablets With Acetaminophen

SPRING VALLEY, N.Y., Oct. 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX),...


29 Jan, 2002, 00:00 ET Par Pharmaceutical Announces Approvable Status of ANDA For Tramadol HCl Tablets

SPRING VALLEY, N.Y., Jan. 29 /PRNewswire-FirstCall/ -- Par Pharmaceutical, a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX), announced...